Loading
A phase 2 trial of propranolol (Hemangeol) in pancreatic cancer, run by Zealand University Hospital, now recruiting.
Examining Safety, Efficacy and Feasibility of Preoperative Propranolol in Patients With PDAC. is a phase 2, randomised interventional study registered as NCT06145074 by Zealand University Hospital, with a registry enrolment figure of 30 participants, started 2024-03-20 and due to reach its primary completion in 2026-12-31. Interventions recorded: Propranolol; Placebo. Conditions listed: Pancreatic Cancer; Surgery. Primary outcome: Preoperative anxiety; Preoperative anxiety and depression; Preoperative quality of life. Pancreatic eligibility wording from the registry: "* Patients with suspected surgically resectable pancreatic cancer". Sites: Denmark. No results are recorded here; the registry entry is the source.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/